Date: Jun 17, 2019 12:00 PM - 04:30 PM
Location: HUCOP - Annex III - Conference Room 214, 2300 Fourth Street NW, Washington, District of Columbia, 20059
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Registration closes on Jun 21, 2019 10:30 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Faculty
- Residents
- Fellows
- Students
Accreditation(s)
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Registration Closed
Registration Closed
Objectives
- Identify current approved immunotherapy agents and their clinical indications
- Describe the underlying physiology and mechanism of action of immunotherapy and its role in treating various malignancies
- Recognize immune-related adverse effects associated with immunotherapy
- Using NCCN guidelines, Outline treatment plans for the management of immunotherapy-related adverse events
- Explain the relevance of the NCCN guidelines in various clinical settings
Speaker(s)/Author(s)
Dr. Eileen Holovac, PharmD, PharmD
|
Activity Number
0010-9999-19-024-L01-P
Date:
06/13/19
Time:
12:00 PM - 01:00 PM
CE Hours
1.00
Registration Closed